Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Pfizer
Sichuan Enray Pharmaceutical Sciences Company
AstraZeneca
Arvinas Inc.
University of Colorado, Denver
Alliance for Clinical Trials in Oncology
Pfizer
University of Nebraska
Zhejiang University
Adela, Inc
Jonsson Comprehensive Cancer Center
Azienda Ospedaliera di Padova
Turning Point Therapeutics, Inc.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Columbia University
Nanjing First Hospital, Nanjing Medical University
Beijing Friendship Hospital